Company page

Simulations Plus, Inc.

Simulations Plus, Inc. (ticker: SLP) is a public company based in the United States with a market capitalization of approximately $368.5 million. The company specializes in software and services for the pharmaceutical and biotechnology industries, focusing on drug discovery and development. Simulations Plus aims to enhance the efficiency of drug development processes through its innovative solutions.